NEW YORK, NY, September 8, 2021 /PRNewswire/ Today, Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient focused biopharmaceutical company, announced the completed safety results in Cohort 1 of its first in human clinical
Full comment from CEO Paul Pereira:
"Alfi bought back as stated $2 mm of their shares. Alfi has a ground breaking technology with a solid leadership team. Alfi platform uses no cookies, is privacy compliant and collects no personal user information
Alfi is the next generation disruptive platform in the digital world and will never always deliver content in an ethical and respectful manner.
EXCLUSIVE: E2open Raises FY22 Guidance Amid Completion Of BluJay Acquisition: Non-GAAP Sales From $369M-$371M To $373M-$375M, Pro Forma Non-GAAP Sales $472M, Combined Co. Sales From ~$558M To ~$570M